Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic medtronic Consolidated — Non-U.S. Developed Markets Revenue (Legacy through FY2024Q4, $M) ($M)
Legacy geographic split reported continuously from FY2016Q1 through FY2024Q4; replaced by unified International division tables starting FY2025Q1.
Latest, Q4 FY24
2,674
Period ended Apr 30, 2024
Change on a year earlier
+1.7%
2,629 in Q4 FY23
History
38 quarters
Since Q3 FY15
Sources
34
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up medtronic consolidated — non-u.s. developed markets revenue (legacy through fy2024q4, $m)
Cite this data
StockData. (2026). Medtronic Medtronic Consolidated — Non-U.S. Developed Markets Revenue (Legacy through FY2024Q4, $M) ($M), quarterly Q3 FY15–Q4 FY24 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/tot-mdt-dev-leg-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.